172 related articles for article (PubMed ID: 25886175)
1. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
Droppert H; Bennett S
Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
[TBL] [Abstract][Full Text] [Related]
2. Corporate social responsibility to improve access to medicines: the case of Brazil.
Thorsteinsdóttir H; Ovtcharenko N; Kohler JC
Global Health; 2017 Feb; 13(1):10. PubMed ID: 28222793
[TBL] [Abstract][Full Text] [Related]
3. How the Process of the CSR Activities Works on Private Hospitals and Pharmaceutical Firms: Multiple Case Study from Strategic Perspective.
Yıldırım M; Dinçer MAM
J Relig Health; 2020 Apr; 59(2):961-985. PubMed ID: 29936676
[TBL] [Abstract][Full Text] [Related]
4. Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.
Dănescu T; Popa MA
Global Health; 2020 Dec; 16(1):117. PubMed ID: 33302949
[TBL] [Abstract][Full Text] [Related]
5. Corporate social responsibility initiatives and their role in firms' reputation and green economic recovery through organizational trust.
Zheng SY; Chen R; Liu H; Li J; Fahad S; Li B
Environ Sci Pollut Res Int; 2023 Sep; 30(45):101817-101828. PubMed ID: 37659017
[TBL] [Abstract][Full Text] [Related]
6. Understanding the dynamics of capital structure, corporate governance, and corporate social responsibility in high- and low-leveraged US and Chinese firms.
Mahmood AN; Arslan HM; Younas ZI; Komal B; Ali K; Mubeen M
Environ Sci Pollut Res Int; 2023 Apr; 30(16):46204-46221. PubMed ID: 36710308
[TBL] [Abstract][Full Text] [Related]
7. The impacts of organizational green culture and corporate social responsibility on employees' responsible behaviour towards the society.
Abbas J; Dogan E
Environ Sci Pollut Res Int; 2022 Aug; 29(40):60024-60034. PubMed ID: 35414156
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Financial Redundancy on Corporate Social Responsibility Performance: Evidence From Chinese Listed Firms.
He L; Gan S; Zhong T
Front Psychol; 2022; 13():882731. PubMed ID: 35664182
[TBL] [Abstract][Full Text] [Related]
9. Corporate social responsibility of pharmaceutical industry in Korea.
Bae G; Ahn JH; Lim KM; Bae S
Front Pharmacol; 2022; 13():950669. PubMed ID: 36081939
[No Abstract] [Full Text] [Related]
10. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
Kato M; Ishikawa H; Okuhara T; Kiuchi T
Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
[TBL] [Abstract][Full Text] [Related]
11. Establishing a corporate social responsibility implementation model for promoting sustainability in the food sector: a hybrid approach of expert mining and ISM-MICMAC.
Usmani MS; Wang J; Ahmad N; Ullah Z; Iqbal M; Ismail M
Environ Sci Pollut Res Int; 2022 Feb; 29(6):8851-8872. PubMed ID: 34494192
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
Sun Y; Li Y
Front Public Health; 2021; 9():710743. PubMed ID: 34604155
[TBL] [Abstract][Full Text] [Related]
13. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
Zhong M; Zhao W; Shahab Y
Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
[TBL] [Abstract][Full Text] [Related]
14. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
[TBL] [Abstract][Full Text] [Related]
15. The illusion of righteousness: corporate social responsibility practices of the alcohol industry.
Yoon S; Lam TH
BMC Public Health; 2013 Jul; 13():630. PubMed ID: 23822724
[TBL] [Abstract][Full Text] [Related]
16. Corporate Social Responsibility Framework: An Innovative Solution to Social Determinants of Health in the USA.
Jain P; Jain B; Dee EC
J Racial Ethn Health Disparities; 2024 Feb; 11(1):7-22. PubMed ID: 36689122
[TBL] [Abstract][Full Text] [Related]
17.
Fernandez-Muiños M; Money K; Saraeva A; Garnelo-Gomez I; Vazquez-Suarez L
Heliyon; 2022 Nov; 8(11):e11930. PubMed ID: 36468134
[TBL] [Abstract][Full Text] [Related]
18. Do Employee Stock Ownership Plans Affect Corporate Social Responsibility? Evidence from China.
Zhou L; Wei F; Kong Y
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162079
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
Front Psychol; 2021; 12():669715. PubMed ID: 35035363
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
Akram A; Tang Y; Tariq J
Front Psychol; 2020; 11():1624. PubMed ID: 32903572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
